SterRx Overview
- Founded
-
2013
- Status
-
Private
- Employees
-
100
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$15M
- Investors
-
2
SterRx General Information
Description
Manufacturer of sterile liquid pharmaceuticals based in Plattsburgh, New York. The company eliminates virtually all human contact with both the manufacturing and packaging processes through the use of robotic automation as well as its finished compounded drug batches are tested for sterility, endotoxin, pH, appearance and potency prior to release, thus providing physicians sterile products for better medical outcomes.
Contact Information
Website
www.sterrx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
- 141 Idaho Avenue
- Plattsburgh, NY 12903
- United States
+1 (518) 000-0000
SterRx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 21-Sep-2017 | $15M | 0000 | Completed | Generating Revenue | |
| 2. Seed Round | 30-Mar-2016 | 000 | Completed | Generating Revenue | ||
| 1. Grant | 22-Dec-2013 | $800K | Completed | Generating Revenue |
SterRx Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Manufacturer of sterile liquid pharmaceuticals based in Plattsburgh, New York. The company eliminates virtually all huma
Pharmaceuticals
Plattsburgh, NY
100
As of 2022
0000
0000000000 0
0000
00000
ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in
0000 000000000
Mumbai, India
00000
As of 0000
00000000
Add Comparison
SterRx Competitors (1)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 00000 | Corporation | Mumbai, India | 00000 | 00000000 |
SterRx Executive Team (4)
SterRx Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Gary Hanley | SterRx | Founder, Manager, Chief Executive Officer & Board Member | 000 0000 |
| Sandra Hawkins | SterRx | Executive Officer & Board Member | 000 0000 |
| Tana Hanley | SterRx | Board Member | 000 0000 |
| Terry Wiley | SterRx | Vice President of Manufacturing, Manager & Board Member | 000 0000 |
SterRx Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
SterRx Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Sagent Pharmaceuticals | Corporation | Minority | 000 0000 | 000000 0 | |
| North Country Regional Economic Development Council | Government | 000 0000 | 000000 0 |